1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 481 F.Supp.2d
  5. 481 F.Supp.2d 437 (2007)
 

GLAXO GROUP LTD. v. LEAVITT

No. AMD 06-469.

481 F.Supp.2d 437 (2007)

GLAXO GROUP LTD., Plaintiff v. Michael O. LEAVITT, et al., Defendants.

United States District Court, D. Maryland.

April 23, 2007.

Attorney(s) appearing for the Case

Mark D. Gately, Steven F. Barley, Hogan and Hartson LLP, Baltimore, MD, Michele Walls Sartori, Hogan and Hartson LLP, Washington, DC, for Plaintiff.

Drake Stephen Cutini, United States Department of Justice Office of Consumer Litigation, Washington, DC, Tarra Deshields Minnis, Office of the United States Attorney, Baltimore, MD, for Defendants.

ORDER

DAVIS, District Judge.

In this court's April 6, 2007, Memorandum Opinion Setting Forth Findings of Fact and Conclusions of Law, the court included findings, inter alia, as to the net profit per unit of generic fluticasone marketed by intervenor Roxane Laboratories, Inc., between February 2006 and September 2006. See ___ F.Supp.2d ___ (D.Md. 2007). The opinion was filed and posted to the Court's website on Friday, April 6, 2007. On Monday...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases